Shidong Jia
About Shidong Jia
Shidong Jia - Education and Expertise
Shidong Jia holds a Medical Doctorate (MD) and a Doctor of Philosophy (PhD) from Harbin Medical University and Peking Union Medical College. His advanced academic training includes postdoctoral work at the Dana-Farber Cancer Institute, affiliated with Harvard University. His educational background encompasses extensive medical and research skills, particularly in oncology and cancer biology.
Shidong Jia - Professional Background
Shidong Jia has a strong professional background in the biotechnology and pharmaceutical industries. He spearheaded oncology biomarker strategies and drug & diagnostics co-development at Genentech. Before that, he held various senior research positions at the Novartis Institutes for BioMedical Research. His professional roles have focused on developing targeted cancer therapies and biomarkers.
Shidong Jia - Achievements in Cancer Research
One of Shidong Jia's significant contributions to cancer research includes identifying p110beta as a novel drug target for PTEN-deficient tumors. His work has been recognized by the P.A.R.T. Investigatorship Award from the Dana-Farber Cancer Institute, highlighting his impact and advances in the field of oncology.
Shidong Jia - Current Role
Shidong Jia is the Founder and CEO of his current venture. In this role, he leverages his extensive experience in oncological research, drug development, and biomarker strategies to steer his company towards innovative solutions in the biomedical field.